Introducing the first oral Bordetella bronchiseptica and canine parainfluenza virus vaccine with proprietary Immuno-Mist-RTM technology

Our proprietary formulation and patented
Immuno-Mist-R™ technology make it possible.

Bordetella bronchiseptica (avirulent live culture), canine parainfluenza virus (modified live virus)

Two of the most common respiratory pathogens vaccinated against are Bordetella bronchiseptica (Bb) and canine parainfluenza virus (Pi). However, an oral combination Bb and Pi vaccine has never been possible—until now.

Vaccinate with a new level of confidence and ease:

  • Groundbreaking Immuno-Mist-RTM technology dramatically
  • increases mucosal surface area contact
  • Broad mucosal coverage induces an effective immune response
  • Oral administration offers comfort for dogs and
  • convenience for staff

Twist, mist, and go!

The first-of-its-kind Immuno-Mist-R™ applicator delivers the vaccine in a fine mist
for greater mucosal coverage than traditional oral vaccines.

Vaccinate against Bb and Pi, together, in 3 easy steps.*

Step 1

Draw vaccine into Luer-lock
syringe and remove the needle.

Step 2

Twist on Immuno-Mist-RTM
applicator until tight.

Step 3

Mist toward the back of the mouth
for can’t-miss coverage.

*Refer to product insert for complete instructions.

How to administer

• 1-mL dose reconstituted prior to administration
• To be administered orally
• Luer-lock syringe and patented Immuno-Mist-RTM
applicator included
• Approved for dogs 7 weeks of age or older

How it works

• 1-mL dose reconstituted prior to administration
• To be administered orally
• Luer-lock syringe and patented Immuno-Mist-RTM
applicator included
• Approved for dogs 7 weeks of age or older

Efficacy

SHORTEN THE DURATION OF COUGHING IN YOUR PATIENTS1

5X SHORTER DURATION OF COUGHING RELATED TO B. BRONCHISEPTICA COMPARED TO CONTROLS1

• 21 dogs were given a 1-mL dose of Nobivac® Intra-Trac® Oral BbPi orally at Day 0
• 21 dogs were given placebo orally at Day 0
• Dogs were challenged 5 weeks post vaccination

PROTECT DOGS WITH SHORT SHEDDING PERIOD1

4x shorter duration of shedding related to
CPiV compared to controls1

• 20 dogs were given 1-mL dose of Nobivac® Intra-Trac® Oral BbPi
orally at Day 0
• 19 dogs were given placebo orally at Day 0
• Dogs were challenged 3 weeks post vaccination

Significantly reduced long-term bacterial
shedding compared to controls1

• 21 dogs were given 1-mL dose of Nobivac® Intra-Trac® Oral BbPi
orally at Day 0
• 21 dogs were given placebo orally at Day 0
• Dogs were challenged 5 weeks post vaccination (Day 36)

Reference: 1. Data on file. Merck Animal Health.

Resources

Nobivac® Intra-Trac® Oral BbPi

DIGITAL DETAILER

Download the full digital detailer for an interactive look at this revolutionary vaccine.